EUVIMEDEUVIMED entdecken
Crossref

Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan

Sho Iwaki iD, Daisuke Kawakita iD, Toshitaka Nagao, Yuichiro Tada iD, Yoshitaka Honma iD, Mizuo Ando, Takuma Matoba iD, Kiyoshi Minohara, Satsuki Nakano, Takayuki Murase, Shinichi Iwasaki, Hiroshi Inagaki iD

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Sho Iwaki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Comprehensive information on genetic alterations in salivary gland cancer (SGC) is limited. This study aimed to elucidate the genetic and clinical characteristics of patients with SGC using the Center for Cancer Genomics and Advanced Therapeutics (C‐CAT) database, a Japanese national genomic database. We analyzed data of 776 patients with SGC registered in the C‐CAT database between June 1, 2019, and June 30, 2023. Adenoid cystic carcinoma was the most common histologic type, followed by salivary duct carcinoma (SDC) and adenocarcinoma not otherwise specified. Genetic data of 681 patients receiving FoundationOne® CDx were analyzed. We identified specific features of the combination of TP53 and CDKN2A alterations among the histological types. Specific LYN amplification was mainly detected in carcinoma ex pleomorphic adenoma and myoepithelial carcinoma. For SDC, the frequency of ERBB2 and BRAF alterations were higher in cases with metastatic lesions than in those with primary lesions. Although 28.6% patients were offered recommended treatment options, only 6.8% received the recommended treatments. This study highlights the differences in genetic alterations among the histological types of SGC, with comprehensive genomic profiling tests revealing lower drug accessibility. These findings could contribute to the development of personalized treatment for patients with SGC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsHumansMaleFemaleJapanAgedMiddle AgedAdultErb-b2 Receptor Tyrosine KinasesAged, 80 and overGenomicsCyclin-Dependent Kinase Inhibitor p16Tumor Suppressor Protein p53Carcinoma, Adenoid CysticDatabases, GeneticCarcinoma, DuctalProto-Oncogene Proteins B-rafYoung AdultAdenocarcinoma

Stichwörter der Autor:innen

Center for Cancer Genomics and Advanced Therapeuticscomprehensive genomic profilingdrug accessibilitygenetic alterationsalivary gland carcinomas

Substanzen

Erb-b2 Receptor Tyrosine KinasesCyclin-Dependent Kinase Inhibitor p16Tumor Suppressor Protein p53Proto-Oncogene Proteins B-rafERBB2 protein, humanCDKN2A protein, humanTP53 protein, humanBRAF protein, human

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Pathology and Molecular Diagnosis, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
  • Department of Head and Neck Oncology and Surgery, Mita Hospital, International University of Health and Welfare, Tokyo, Japan.
  • Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

ORCID-Profile: Sho Iwaki, Daisuke Kawakita, Yuichiro Tada, Yoshitaka Honma, Takuma Matoba, Hiroshi Inagaki

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Iwaki, S., Kawakita, D., Nagao, T., Tada, Y., Honma, Y., Ando, M., Matoba, T., Minohara, K., Nakano, S., Murase, T., Iwasaki, S., & Inagaki, H. (2024). Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan. International Journal of Cancer. https://doi.org/10.1002/ijc.34972

Vancouver

Iwaki S, Kawakita D, Nagao T, Tada Y, Honma Y, Ando M, et al. Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan. International Journal of Cancer. 2024. doi:10.1002/ijc.34972

BibTeX
@article{Iwaki2024,
  author = {Iwaki, Sho and Kawakita, Daisuke and Nagao, Toshitaka and Tada, Yuichiro and Honma, Yoshitaka and Ando, Mizuo and Matoba, Takuma and Minohara, Kiyoshi and Nakano, Satsuki and Murase, Takayuki and Iwasaki, Shinichi and Inagaki, Hiroshi},
  title = {Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34972}
}
Kostenlos starten →